Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases

Jacques Lux, Alexander G. White, Minnie Chan, Carolyn J. Anderson, Adah Almutairi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Metals are essential in medicine for both therapy and diagnosis. We recently created the first metal-chelating nanogel imaging agent, which employed versatile, reproducible chemistry that maximizes chelation stability. Here we demonstrate that our metal chelating crosslinked nanogel technology is a powerful platform by incorporating 64Cu to obtain PET radiotracers. Polyacrylamide-based nanogels were crosslinked with three different polydentate ligands (DTPA, DOTA, NOTA). NOTA-based nanogels stably retained 64Cu in mouse serum and accumulated in tumors in vivo as detected by PET/CT imaging. Measurement of radioactivity in major organs ex vivo confirmed this pattern, revealing a high accumulation (12.3% ID/g and 16.6% ID/g) in tumors at 24 and 48 h following administration, with lower accumulation in the liver (8.5% ID/g at 24 h) and spleen (5.5% ID/g). Nanogels accumulated even more efficiently in metastases (29.9% and 30.4% ID/g at 24 and 48 h). These metal-chelating nanogels hold great promise for future application as bimodal PET/MRI agents; chelation of β-emitting radionuclides could enable radiation therapy.

Original languageEnglish (US)
Pages (from-to)277-288
Number of pages12
JournalTheranostics
Volume5
Issue number3
DOIs
StatePublished - Jan 1 2015

Fingerprint

Copper
Metals
Neoplasm Metastasis
Neoplasms
Pentetic Acid
Radioisotopes
Radioactivity
NanoGel
Radiotherapy
Spleen
Medicine
Ligands
Technology
Liver
Serum
1,4,7-triazacyclononane-N,N',N''-triacetic acid
Therapeutics

Keywords

  • Copper 64
  • Metal-chelating crosslinkers
  • Metastases
  • Nanogels
  • NOTA
  • PET
  • Preclinical imaging

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases. / Lux, Jacques; White, Alexander G.; Chan, Minnie; Anderson, Carolyn J.; Almutairi, Adah.

In: Theranostics, Vol. 5, No. 3, 01.01.2015, p. 277-288.

Research output: Contribution to journalArticle

Lux, Jacques ; White, Alexander G. ; Chan, Minnie ; Anderson, Carolyn J. ; Almutairi, Adah. / Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases. In: Theranostics. 2015 ; Vol. 5, No. 3. pp. 277-288.
@article{4b9a6238a0c244deb472e12949e2dcd1,
title = "Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases",
abstract = "Metals are essential in medicine for both therapy and diagnosis. We recently created the first metal-chelating nanogel imaging agent, which employed versatile, reproducible chemistry that maximizes chelation stability. Here we demonstrate that our metal chelating crosslinked nanogel technology is a powerful platform by incorporating 64Cu to obtain PET radiotracers. Polyacrylamide-based nanogels were crosslinked with three different polydentate ligands (DTPA, DOTA, NOTA). NOTA-based nanogels stably retained 64Cu in mouse serum and accumulated in tumors in vivo as detected by PET/CT imaging. Measurement of radioactivity in major organs ex vivo confirmed this pattern, revealing a high accumulation (12.3{\%} ID/g and 16.6{\%} ID/g) in tumors at 24 and 48 h following administration, with lower accumulation in the liver (8.5{\%} ID/g at 24 h) and spleen (5.5{\%} ID/g). Nanogels accumulated even more efficiently in metastases (29.9{\%} and 30.4{\%} ID/g at 24 and 48 h). These metal-chelating nanogels hold great promise for future application as bimodal PET/MRI agents; chelation of β-emitting radionuclides could enable radiation therapy.",
keywords = "Copper 64, Metal-chelating crosslinkers, Metastases, Nanogels, NOTA, PET, Preclinical imaging",
author = "Jacques Lux and White, {Alexander G.} and Minnie Chan and Anderson, {Carolyn J.} and Adah Almutairi",
year = "2015",
month = "1",
day = "1",
doi = "10.7150/thno.10904",
language = "English (US)",
volume = "5",
pages = "277--288",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "3",

}

TY - JOUR

T1 - Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases

AU - Lux, Jacques

AU - White, Alexander G.

AU - Chan, Minnie

AU - Anderson, Carolyn J.

AU - Almutairi, Adah

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Metals are essential in medicine for both therapy and diagnosis. We recently created the first metal-chelating nanogel imaging agent, which employed versatile, reproducible chemistry that maximizes chelation stability. Here we demonstrate that our metal chelating crosslinked nanogel technology is a powerful platform by incorporating 64Cu to obtain PET radiotracers. Polyacrylamide-based nanogels were crosslinked with three different polydentate ligands (DTPA, DOTA, NOTA). NOTA-based nanogels stably retained 64Cu in mouse serum and accumulated in tumors in vivo as detected by PET/CT imaging. Measurement of radioactivity in major organs ex vivo confirmed this pattern, revealing a high accumulation (12.3% ID/g and 16.6% ID/g) in tumors at 24 and 48 h following administration, with lower accumulation in the liver (8.5% ID/g at 24 h) and spleen (5.5% ID/g). Nanogels accumulated even more efficiently in metastases (29.9% and 30.4% ID/g at 24 and 48 h). These metal-chelating nanogels hold great promise for future application as bimodal PET/MRI agents; chelation of β-emitting radionuclides could enable radiation therapy.

AB - Metals are essential in medicine for both therapy and diagnosis. We recently created the first metal-chelating nanogel imaging agent, which employed versatile, reproducible chemistry that maximizes chelation stability. Here we demonstrate that our metal chelating crosslinked nanogel technology is a powerful platform by incorporating 64Cu to obtain PET radiotracers. Polyacrylamide-based nanogels were crosslinked with three different polydentate ligands (DTPA, DOTA, NOTA). NOTA-based nanogels stably retained 64Cu in mouse serum and accumulated in tumors in vivo as detected by PET/CT imaging. Measurement of radioactivity in major organs ex vivo confirmed this pattern, revealing a high accumulation (12.3% ID/g and 16.6% ID/g) in tumors at 24 and 48 h following administration, with lower accumulation in the liver (8.5% ID/g at 24 h) and spleen (5.5% ID/g). Nanogels accumulated even more efficiently in metastases (29.9% and 30.4% ID/g at 24 and 48 h). These metal-chelating nanogels hold great promise for future application as bimodal PET/MRI agents; chelation of β-emitting radionuclides could enable radiation therapy.

KW - Copper 64

KW - Metal-chelating crosslinkers

KW - Metastases

KW - Nanogels

KW - NOTA

KW - PET

KW - Preclinical imaging

UR - http://www.scopus.com/inward/record.url?scp=84924300069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924300069&partnerID=8YFLogxK

U2 - 10.7150/thno.10904

DO - 10.7150/thno.10904

M3 - Article

C2 - 25553115

AN - SCOPUS:84924300069

VL - 5

SP - 277

EP - 288

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 3

ER -